Asia Pacific Skin Cancer Diagnostics Market Size, Share & Trends Analysis Report By Type (Non-Melanoma and Melanoma), By Test Type (Skin Biopsy, Imaging Tests, Dermatoscopy, Lymph Node Biopsy, and Others), ByEnd-use, By Country and Growth Forecast, 2024 - 2031

The Asia Pacific Skin Cancer Diagnostics Market would witness market growth of 5.9% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Skin Cancer Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $851.6 million by 2031. The Japan market is registering a CAGR of 5.4% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 6.7% during (2024 - 2031).

The skin cancer diagnostics market is experiencing substantial growth due to the increasing cost of healthcare, which is indicative of the broader patterns in global health investment. According to the World Health Organization (WHO), global healthcare spending reached $8.3 trillion in 2020, accounting for approximately 10% of global GDP.

Moreover, Various factors fuel this upward trajectory in healthcare spending, including aging populations, advances in medical technology, and increased awareness and diagnosis of health conditions, including skin cancer.

Many countries within the Asia Pacific region are undergoing significant advancements in healthcare infrastructure. This includes the establishment of new hospitals, clinics, and diagnostic facilities. Improved access to these facilities fosters a more proactive approach to skin cancer screening and diagnosis. China has experienced a significant rise in skin cancer incidence, partly due to the rapid development of healthcare infrastructure.

Free Valuable Insights: The Global Skin Cancer Diagnostics Market is Predict to reach USD 12.8 Billion by 2031, at a CAGR of 5.3%

Based on Type, the market is segmented into Non-Melanoma and Melanoma. Based on Test Type, the market is segmented into Skin Biopsy, Imaging Tests, Dermatoscopy, Lymph Node Biopsy, and Others. Based on End-use, the market is segmented into Hospital & Clinics, Laboratories, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Castle Biosciences, Inc.
• Bausch Health Companies, Inc. (DermTech, Inc.)
• Canfield Scientific, Inc.
• DermaSensor, Inc.
• F.Hoffmann-La Roche Ltd.
• NeoGenomics, Inc.
• Quest Diagnostics Incorporated.
• Digital Diagnostics, Inc. (3Derm Systems, Inc.)
• FotoFinder Systems GmbH
• Veriskin Inc

Asia Pacific Skin Cancer Diagnostics Market Report Segmentation

By Type

• Non-Melanoma
• Melanoma

By Test Type

• Skin Biopsy
• Imaging Tests
• Dermatoscopy
• Lymph Node Biopsy
• Others

By End-use

• Hospital & Clinics
• Laboratories
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Skin Cancer Diagnostics Market, by Type
1.4.2 Asia Pacific Skin Cancer Diagnostics Market, by Test Type
1.4.3 Asia Pacific Skin Cancer Diagnostics Market, by End-use
1.4.4 Asia Pacific Skin Cancer Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Skin Cancer Diagnostics Market by Type
4.1 Asia Pacific Non-Melanoma Market by Country
4.2 Asia Pacific Melanoma Market by Country

Chapter 5. Asia Pacific Skin Cancer Diagnostics Market by Test Type
5.1 Asia Pacific Skin Biopsy Market by Country
5.2 Asia Pacific Imaging Tests Market by Country
5.3 Asia Pacific Dermatoscopy Market by Country
5.4 Asia Pacific Lymph Node Biopsy Market by Country
5.5 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Skin Cancer Diagnostics Market by End-use
6.1 Asia Pacific Hospital & Clinics Market by Country
6.2 Asia Pacific Laboratories Market by Country
6.3 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Skin Cancer Diagnostics Market by Country
7.1 China Skin Cancer Diagnostics Market
7.1.1 China Skin Cancer Diagnostics Market by Type
7.1.2 China Skin Cancer Diagnostics Market by Test Type
7.1.3 China Skin Cancer Diagnostics Market by End-use
7.2 Japan Skin Cancer Diagnostics Market
7.2.1 Japan Skin Cancer Diagnostics Market by Type
7.2.2 Japan Skin Cancer Diagnostics Market by Test Type
7.2.3 Japan Skin Cancer Diagnostics Market by End-use
7.3 India Skin Cancer Diagnostics Market
7.3.1 India Skin Cancer Diagnostics Market by Type
7.3.2 India Skin Cancer Diagnostics Market by Test Type
7.3.3 India Skin Cancer Diagnostics Market by End-use
7.4 South Korea Skin Cancer Diagnostics Market
7.4.1 South Korea Skin Cancer Diagnostics Market by Type
7.4.2 South Korea Skin Cancer Diagnostics Market by Test Type
7.4.3 South Korea Skin Cancer Diagnostics Market by End-use
7.5 Singapore Skin Cancer Diagnostics Market
7.5.1 Singapore Skin Cancer Diagnostics Market by Type
7.5.2 Singapore Skin Cancer Diagnostics Market by Test Type
7.5.3 Singapore Skin Cancer Diagnostics Market by End-use
7.6 Malaysia Skin Cancer Diagnostics Market
7.6.1 Malaysia Skin Cancer Diagnostics Market by Type
7.6.2 Malaysia Skin Cancer Diagnostics Market by Test Type
7.6.3 Malaysia Skin Cancer Diagnostics Market by End-use
7.7 Rest of Asia Pacific Skin Cancer Diagnostics Market
7.7.1 Rest of Asia Pacific Skin Cancer Diagnostics Market by Type
7.7.2 Rest of Asia Pacific Skin Cancer Diagnostics Market by Test Type
7.7.3 Rest of Asia Pacific Skin Cancer Diagnostics Market by End-use

Chapter 8. Company Profiles
8.1 Castle Biosciences, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.1.4.2 Acquisition and Mergers:
8.1.5 SWOT Analysis
8.2 Bausch Health Companies, Inc.(DermTech, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Canfield Scientific, Inc.
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 DermaSensor, Inc.
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Neogenomics, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Quest Diagnostics Incorporated
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Recent strategies and developments:
8.7.4.1 Partnerships, Collaborations, and Agreements:
8.7.4.2 Acquisition and Mergers:
8.7.5 SWOT Analysis
8.8 Digital Diagnostics, Inc.(3Derm Systems, Inc.)
8.8.1 Company Overview
8.9 FotoFinder Systems GmbH
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. VERISKIN INC.
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 Asia Pacific Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 2 Asia Pacific Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 3 Asia Pacific Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 4 Asia Pacific Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 5 Asia Pacific Non-Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 6 Asia Pacific Non-Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 7 Asia Pacific Melanoma Market by Country, 2020 - 2023, USD Million
TABLE 8 Asia Pacific Melanoma Market by Country, 2024 - 2031, USD Million
TABLE 9 Asia Pacific Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 10 Asia Pacific Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 11 Asia Pacific Skin Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 12 Asia Pacific Skin Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 13 Asia Pacific Imaging Tests Market by Country, 2020 - 2023, USD Million
TABLE 14 Asia Pacific Imaging Tests Market by Country, 2024 - 2031, USD Million
TABLE 15 Asia Pacific Dermatoscopy Market by Country, 2020 - 2023, USD Million
TABLE 16 Asia Pacific Dermatoscopy Market by Country, 2024 - 2031, USD Million
TABLE 17 Asia Pacific Lymph Node Biopsy Market by Country, 2020 - 2023, USD Million
TABLE 18 Asia Pacific Lymph Node Biopsy Market by Country, 2024 - 2031, USD Million
TABLE 19 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 20 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 21 Asia Pacific Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 22 Asia Pacific Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 23 Asia Pacific Hospital & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 24 Asia Pacific Hospital & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 25 Asia Pacific Laboratories Market by Country, 2020 - 2023, USD Million
TABLE 26 Asia Pacific Laboratories Market by Country, 2024 - 2031, USD Million
TABLE 27 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 28 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 29 Asia Pacific Skin Cancer Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 30 Asia Pacific Skin Cancer Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 31 China Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 32 China Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 33 China Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 34 China Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 35 China Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 36 China Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 37 China Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 38 China Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 39 Japan Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 40 Japan Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 41 Japan Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 42 Japan Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 43 Japan Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 44 Japan Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 45 Japan Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 46 Japan Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 47 India Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 48 India Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 49 India Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 50 India Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 51 India Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 52 India Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 53 India Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 54 India Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 55 South Korea Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 56 South Korea Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 57 South Korea Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 58 South Korea Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 59 South Korea Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 60 South Korea Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 61 South Korea Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 62 South Korea Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 63 Singapore Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 64 Singapore Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 65 Singapore Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 66 Singapore Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 67 Singapore Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 68 Singapore Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 69 Singapore Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 70 Singapore Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 71 Malaysia Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 72 Malaysia Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 73 Malaysia Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 74 Malaysia Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 75 Malaysia Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 76 Malaysia Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 77 Malaysia Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 78 Malaysia Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 79 Rest of Asia Pacific Skin Cancer Diagnostics Market, 2020 - 2023, USD Million
TABLE 80 Rest of Asia Pacific Skin Cancer Diagnostics Market, 2024 - 2031, USD Million
TABLE 81 Rest of Asia Pacific Skin Cancer Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 82 Rest of Asia Pacific Skin Cancer Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 83 Rest of Asia Pacific Skin Cancer Diagnostics Market by Test Type, 2020 - 2023, USD Million
TABLE 84 Rest of Asia Pacific Skin Cancer Diagnostics Market by Test Type, 2024 - 2031, USD Million
TABLE 85 Rest of Asia Pacific Skin Cancer Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 86 Rest of Asia Pacific Skin Cancer Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 87 Key Information – Castle Biosciences, Inc.
TABLE 88 key information – Bausch Health Companies, Inc.
TABLE 89 Key Information – Canfield Scientific, Inc.
TABLE 90 Key Information – Dermasensor, Inc.
TABLE 91 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 92 Key Information – neogenomics, inc.
TABLE 93 Key information – Quest Diagnostics Incorporated
TABLE 94 Key Information – Digital Diagnostics, Inc.
TABLE 95 Key Information – FotoFinder Systems GmbH
TABLE 96 Key Information – Veriskin Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Skin Cancer Diagnostics Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Skin Cancer Diagnostics Market
FIG 4 Porter’s Five Forces Analysis – Skin Cancer Diagnostics Market
FIG 5 Asia Pacific Skin Cancer Diagnostics Market share by Type, 2023
FIG 6 Asia Pacific Skin Cancer Diagnostics Market share by Type, 2031
FIG 7 Asia Pacific Skin Cancer Diagnostics Market by Type, 2020 - 2031, USD Million
FIG 8 Asia Pacific Skin Cancer Diagnostics Market share by Test Type, 2023
FIG 9 Asia Pacific Skin Cancer Diagnostics Market share by Test Type, 2031
FIG 10 Asia Pacific Skin Cancer Diagnostics Market by Test Type, 2020 - 2031, USD Million
FIG 11 Asia Pacific Skin Cancer Diagnostics Market share by End-use, 2023
FIG 12 Asia Pacific Skin Cancer Diagnostics Market share by End-use, 2031
FIG 13 Asia Pacific Skin Cancer Diagnostics Market by End-use, 2020 - 2031, USD Million
FIG 14 Asia Pacific Skin Cancer Diagnostics Market share by Country, 2023
FIG 15 Asia Pacific Skin Cancer Diagnostics Market share by Country, 2031
FIG 16 Asia Pacific Skin Cancer Diagnostics Market by Country, 2020 - 2031, USD Million
FIG 17 SWOT analysis: Castle Biosciences, Inc.
FIG 18 SWOT Analysis: Bausch Health Companies, Inc.
FIG 19 SWOT Analysis: Canfield Scientific, Inc.
FIG 20 SWOT analysis: DermaSensor, Inc.
FIG 21 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 22 Swot Analysis: Neogenomics, Inc.
FIG 23 SWOT Analysis: Quest Diagnostics Incorporated
FIG 24 SWOT Analysis: FotoFinder Systems GmbH
FIG 25 SWOT analysis: VERISKIN INC.